Spinogenix, the company behind the once-a-day pill that restored lost nerve cell connections in people with amyotrophic ...

A group of eight molecules in the blood can be used as a biomarker to distinguish ALS from other neurodegenerative conditions ...

To be able to manage important aspects of my environment and control access to entertainment gives me back the independence ...

Direct-to-participant study to reach 150 people living with ALS, with 2 participants already enrolled.

Mayo Clinic in Florida has received a grant from the National Institute of Neurological Disorders and Stroke (NIDS) to begin an innovative study that will provide hundreds of patients with amyotrophic ...

A blood test has been shown to accurately identify patients with amyotrophic lateral sclerosis at early stages, which could ...

Schlieren, Zurich/Switzerland, September 24, 2024 - Mabylon AG, a leader in the high-throughput discovery, characterization, and development of human-derived antibodies, today announced that it has ...

Jason McCarthy, an analyst from Maxim Group, maintained the Buy rating on Brainstorm Cell Therapeutics (BCLI – Research Report). The ...

The following is a summary of “How to detect affect recognition alterations in amyotrophic lateral sclerosis,” published in the September 2024 issue of Neurology by Castelnovo et al. Researchers condu ...

(Lawrenceburg, IN) – The 8th annual Cruisin’ to a Cure for ALS (Amyotrophic Lateral Sclerosis) car show in Lawrenceburg set ...

About Rozebalamin (generic name: mecobalamin, development code: E0302) ...

Mabylon AG, a leader in the high-throughput discovery, characterization, and development of human-derived antibodies, today announced that it has received three grants totaling more ...